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morphology, mtDNA copy number, mPTP, oxygen consumption and
ATP/ADP ratio were evaluated. Although showing equal amounts of
mtDNA and Tom20 protein, CSC have round and small depolarized
mitochondria, while dCC show a polarized and ﬁlamentous mito-
chondrial network with higher oxygen consumption and ATP/ADP
content. The mitochondrial transcription factor (mTFA) appears on its
inactive form in CSC, which occurs with a lower content of the
mtDNA-encoded subunit MT-CO1 in this experimental group. Our
results showed differences in the expression of some classical
components/regulators of the mPTP: cyclophylin D is more present
in CSC, while the adenine nucleotide translocator (ANT) is more
present in dCC. Moreover, cobalt quenching of calcein mitochondrial
ﬂuorescence as an end-point for mPTP opening shows a 40% decrease
in dCC vs CSC. Cyclosporin A inhibits cobalt quenching in CSC,
increasing ﬂuorescence up to 127%, not showing signiﬁcant inhibition
in dCC. In addition, cleaved caspase 3 is expressed in CSC; however,
caspase 3, 8 and 9-like activities are higher in dCC, demonstrating a
non-death role for caspase 3 on CSC. P19 cells were also grown in
galactose/glutamine-containing media to force a metabolic remodel-
ing to oxidative phosphorylation. In this case, the galactose/glutamine
media decreased the cell proliferation rate and induced differentia-
tion of CSC.
In conclusion, CSC quiescent mitochondria contribute for their
glycolytic proﬁle maintaining their stemness. Stimulation of mito-
chondrial activity may render CSCs prone to chemotherapy.
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Thyroid hormones (THs) are recognized key regulators of
mitochondrial biology. Key elements of the hypothalamic-pituitary-
thyroid (HPT) axis are expressed in human skin, and TRH (thyrotro-
pin-release hormone) and TSH (thyrotropin) are potent regulators of
the mitochondrial biology of human epidermis [1,2]. Arguing that
hair shaft production and hair follicle (HF) cycling are highly energy-
consuming processes, we asked whether and how TRH, TSH and the
THs triiodothyronine (T3) and thyroxine (T4) also impact on the
mitochondrial biology of human scalp HFs. Therefore, microdissected
human HFs were treated with T3 (100 pM), T4 (100 nM), TRH
(30 nM) or TSH (100 mU/mL) for 24 h in human HF organ culture.
This revealed increased gene and protein expression of MTCO1 and
TFAM by RT-qPCR and immunostaining. Moreover TRH, TSH and THs
stimulated mitochondrial energy metabolism in HFs, i.e. complex I
(NBT reduction assay) and IV activity (cytochrome c oxidation).
Increased heat production (measured by calorimetry) after T3
treatment conﬁrmed this. In addition TRH, TSH, T3 and T4 stimulated
intrafollicular mitochondrial biogenesis, as demonstrated by in-
creased porin immunoreactivity (voltage-dependent-anion-channel,
VDAC1) and an increased number of ultrastructurally detectable
perinuclear mitochondria by transmission electron microscopy.
Since increased mitochondrial activity can also be detrimental via
enhanced ROS-mediated oxidative damage, we checked ROS produc-
tion in human outer root sheath (ORS) keratinocytes after HPT axis
hormone treatment. This did not alter the basal level of ROS. Instead,
T3 and T4 even reduced H2O2-induced increased intrafollicular ROS
production. In addition by RT-qPCR we found a signiﬁcant increase of
catalase mRNA level in treated ORS keratinocytes, whereas SOD2
mRNA level was increased just in TSH and T4 treatment.
These data provide the ﬁrst evidence that energy metabolism,
mitochondrial function and redox state of human HFs are subject to
profound (neuro-)endocrine regulation by all four key players of the
HPT axis: TRH, TSH, T4 and T3, two of which are even locally generated.
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In yeast Saccharomyces cerevisiae, one of tRNAsLys (tRNALys or
tRK1) is partially associated with mitochondria and functioning in
mitochondrial translation which becomes essential in temperature
stress conditions. Its inhibition also causes a conditional phenotype of
mitochondrial deﬁciency [1,2]. Import of tRK1 has ATP/ΔΨ dependent
character and it has been shown that tRK1 has to be aminoacylated in
the cytosol by the lysyl-tRNA-synthetase (KRS) and that its import
requires two cytosolic targeting factors— the enolase-2, an enzyme of
the glycolytic pathway, and the cytosolic precursor of the mitochon-
drial lysyl-tRNA-synthetase (preMSK) [3,4].
However, in spite of that import of tRK1 requires the preMSKand their
co-import through the pre-protein import machinery may be suggested,
analysis of yeast strains, carrying deletions of non-essential genes coding
for proteins of the pre-protein import machinery revealed that none of
these mutations had an effect on tRK1 import. Additional experiments
with recombinant fusion protein cytb2-DHFR (consists of ﬁrst 167 amino
acids of cytochrome b2 and entire mouse dihydrofolate reductase) [5]
conﬁrmed that after blockage of TOM40 channel approximately half
of tRK1 still was imported to mitochondria. With the help of North-
Western analysis combined with tandem mass spectrometry (MALDI
TOF) several proteins, among which mitochondrial porins 1, 2 (Por1,
Por2) and TOM40 were identiﬁed as potential binders of tRK1 upon
its import into mitochondria.
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Surprisingly, whereas for a long time Por2 was not considered to
have a channel activity [6], mitochondria from ΔPOR1 strain imported
signiﬁcant amount of tRK1 in presence of cytb2-DHFR. Experiments
with vesicles prepared from outer membrane of wild type and
ΔPOR1,2mitochondria conﬁrmed the essential role of Por2 protein in
tRK1 import. Finally, ﬁrst time isolated homogenous Por2 was
reconstituted into small unilamellar vesicles and planar phospholipid
bilayer membranes. With proteoliposomes it was shown that Por2
provides transport of carbohydrates and nucleotides across the
membrane with the same kinetic as for Por1 and on bilayer system
cation selective channels were registered with conductivity about
2 nS and closure with voltage above 30 mV in pH dependent manner.
Physiological role of Por2 and downregulation mechanism of its
channel activity in mitochondrial outer membrane are discussed.
An understanding of the ﬁne mechanisms of tRNA import from
cytosol could help us to improve delivery of “therapeutic” RNA
molecules into mitochondria to cure at themolecular level the negative
effects of mutations of tRNA genes coded by the mitochondrial DNA
causes large number of human diseases, such as Mitochondrial
Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)
or Myoclonic Epilepsy with Ragged Red Fibers (MERRF) [7].
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The growth factor adaptor protein, p66Shc, has a substantial
impact on mitochondrial metabolism through regulation of cellular
response to oxidative stress [1]. Low level of the p66Shc protein or its
complete ablation protects against numerous age-related disorders
and may partially prevent pathologies caused by reactive oxygen
species (ROS). On the other hand, high level of p66Shc has been
correlated with increased intracellular ROS production [2].
In our studies we have shown that both extracellular and intra-
cellular oxidative stresses can trigger phosphorylation of p66Shc at
Ser36 leading to increased ROS production. Fibroblasts derived from
patients with deﬁned variousmitochondrial disorders have been used
as a model of a self-propelling intracellular oxidative stress. Detailed
characterization of bioenergetic parameters and ROS production in
cells harboring mitochondrial defects showed that ﬁbroblasts from
patients demonstrate an increased ROS production compared to
control cells. We have also observed alterations in the antioxidant
defense system, decreased levels of electron transfer chain complexes
and attenuated oxidative chain activity of the patient cells. Observed
mitochondrial dysfunctions correlated with the increased status of
p66Shc phosphorylation at Ser36. In order to decrease the global and
p66Shc-related ROS generation in patient cells we tested a series of
chemical compounds demonstrating antioxidant capacities (with
different intracellular localization and speciﬁcity for different ROS
molecules) as well as kinase inhibitors (targeted against kinases
involved in the p66Shc phosphorylation at Ser36).
Alterations in the p66Shc phosphorylation pathways or adminis-
tration of mitochondrially targeted antioxidants seems to be a
promising way to stop the vicious circle of ROS induced p66Shc
phosphorylation‐related ROS production. This approach may open
new possibilities for pharmacological interventions that could
minimize the cellular effects of p66Shc phosphorylation in case of
pathological intracellular oxidative stress.
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Neoplasias uncouple anabolic glucose utilization from oxygen
availability to sustain unrestrained growth when oxygen and
nutrients are scarce, but the concomitant decrease in mitochondrial
respiration potentially exposes cancer cells to oxidative stress. We
report that the mitochondrial chaperone TRAP1, which is induced in
most tumor types, is required for neoplastic growth, and confers
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